Abstract: The present invention relates to the field of molecular biology and cell biology. More specifically, the present invention relates to a CRISPR-CAS system for a yeast host cell.

Abstract: Provided is a process to produce a yeast-derived product as well as a yeast autolysate or yeast extract comprising at least 1% w/w reducing sugar based on the total dry matter weight of the yeast extract or yeast autolysate. Also provided is a process to produce a reaction flavour. The yeast extract or yeast autolysate is very suitable for the production of a reaction flavour.

Abstract: The present invention relates to a method for a dicarboxylic acid, which method comprises fermenting fungal cells in a vessel comprising a suitable fermentation medium, wherein a least a portion of the fungal cells are reused in the presence of a vitamin and/or a trace element.

Abstract: Polymer composition containing a thermoplastic polyester elastomer, which contains hard segments of a polyester and soft segments, that contain monomer units of a dimerised fatty acid and/or a derivative thereof, which polymer composition contains at least 0.1 wt % of a UV-absorber.

Abstract: The present invention provides systems for producing engineered oleaginous yeast or fungi that express carotenoids.

Abstract: A process for producing a product having a fish flavor is provided, the process comprising preparing a composition comprising 1-20% w/w water and at least a polyunsaturated fatty acid, incubating the composition at less than 260° C. and at a reaction time sufficient for the fish flavor to develop, and optionally mixing the product with one or more other ingredients. The product obtainable by this process and methods for using the same are also provided.

Abstract: The invention relates to a process for making a polyethylene multifilament yarn comprising the steps of a) spinning multiple filaments from a solution comprising between 0.5 and 30 mass % of ultra high molecular weight polyethylene in a solvent; b) cooling the filament obtained to form gel filaments; c) removing at least partly the solvent from the gel filaments; d) drawing the filaments in at least one drawing step before, during or after removing the solvent, wherein the solution of step a) further comprises between 0.1 and 7 mass % of a sorbitol derivative and at step d) the filaments are drawn with a draw ratio of more than 15 to a strength of at least 1 GPa. The invention further relates to a high performance polyethylene multifilament yarn having a strength of at least 1 GPa, wherein the yarn comprises between 0.1 and 5 mass % of a sorbitol derivative.

Abstract: Process for preparing a macromonomer using free radical-initiated aqueous emulsion polymerisation in a polymerisation reactor of at least one olefinically unsaturated monomer, which process employs a hydrophobic Co chelate complex as a CTA, a stabilising substance(s) for the emulsion polymerisation process and a monomer feed stage MF; wherein an aqueous pre-emulsified mixture A, comprising at least part of the Co chelate(s) employed, at least part of the stabilising substance(s) employed, and (i) a non-polymerisable organic solvent(s) and/or (ii) a polymerisable monomer(s) in unpolymerised or at least partially polymerised form, is contacted in the reactor with monomer(s) of feed stage MF at the beginning of and/or during the course of feed stage MF; and wherein in mixture A the weight ratio of (i) and/or (ii) to the stabilising substance(s) is in the range of from 10/1 to 1/10.

Abstract: A process is provided for preparing urea-containing polymers by contacting a hydroxy-functional organic compound having a functionality of two or more, with a coupling agent in the presence of a strong base, wherein the coupling agent is a carbonylbislactam compound having the general formula (I): wherein n is an integer from 3 to 15, and that the contacting is conducted at a temperature between 0° C. and 80° C. The polymers thus obtained are believed to be new and are useful e.g. in tissue engineering and coatings applications.

Abstract: Ampicillin is produced in a batch process by enzymatic acylation of 6-aminopenicillanic acid (6-APA) with the aid of phenylglycine derivative such as D-phenylglycine amide. High conversions of phenylglycine derivative may be achieved by having the total concentration in the reaction mixture of 6-APA and ampicillin greater than 250 mM and the molar ration of total quantity of phenylglycine derivative to total quantity of 6-APA less than 2.5. Higher yields of ampicillin may be achieved when the amount of dissolved 6-APA is kept low, e.g. below 300 mM.